MedTrace Logo

Posterior Capsule Opacification Following Cataract Surgery With Implantation of the MICS IOL L313

NCT03184428 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3785

Last updated 2020-04-29

Study results available
· View outcomes & findings →

Summary

This study collects intra- and postoperative data from the patients´charts retrospectively and evaluates retro- and prospectively the rate of posterior capsule opacification (PCO) following implantation of the intraocular lens L 313.

Conditions

  • Posterior Capsule Opacification

Interventions

OTHER

Postoperative observation and survey

For postoperative Observation with a survey we ask the patients (or in case of no information the ophthalmologist) whether they had undergone a YAG-Laser-Capsulotomy after Cataract-Surgery or not.

Sponsors & Collaborators

  • Dietrich-Bonhoeffer-Klinikum

    lead INDUSTRY

Principal Investigators

  • Helmut Hoeh, Prof. Dr. · Department of Ophthalmology, Neubrandenburg, Germany

  • Christoforos Stylianides · Department of Ophthalmology, Neubrandenburg, Germany

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-01
Primary Completion
2018-03-01
Completion
2018-12-10

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03184428 on ClinicalTrials.gov